JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB65614

Caspase-8 (active) FITC Staining Kit

Be the first to review this product! Submit a review

|

(8 Publications)

Caspase 8 (active) FITC Staining Kit (ab65614) provides a convenient means for sensitive detection of activated caspase 8 in living cells.

View Alternative Names

MCH5, CASP8, Caspase-8, CASP-8, Apoptotic cysteine protease, Apoptotic protease Mch-5, CAP4, FADD-homologous ICE/ced-3-like protease, FADD-like ICE, ICE-like apoptotic protease 5, MORT1-associated ced-3 homolog, FLICE, MACH

4 Images
Functional Studies - Caspase-8 (active) FITC Staining Kit (AB65614)
  • FuncS

Unknown

Functional Studies - Caspase-8 (active) FITC Staining Kit (AB65614)

Active caspase 8 in control Jurkat cells (10e6/mL) or cells treated for five hours with 10 ug/mL Cyclohexamide (CHX) (ab120093) or four hours with 25 ug/mL Mitomycin C (MitoC) (ab120797). Background signal subtracted, duplicates; +/- SD.

Functional Studies - Caspase-8 (active) FITC Staining Kit (AB65614)
  • FuncS

Lab

Functional Studies - Caspase-8 (active) FITC Staining Kit (AB65614)

Active caspase 8 in Jurkat cells following four hours exposure to 50 ng/mL anti-Fas Ab (αFas) (MBL), five hours with 10 μg/mL cyclohexamide (CHX) (ab120093), or one hour pretreatment with CHX followed by four hours with αFas. Background signal subtracted, duplicates; +/- SD.

Flow Cytometry - Caspase-8 (active) FITC Staining Kit (AB65614)
  • Flow Cyt

PubMed

Flow Cytometry - Caspase-8 (active) FITC Staining Kit (AB65614)

Caspase 8 activation of Hela (left) and SiHa (right) cells after in vitro treatment with pentoxylline (PTX) or cisplatin (CIS) either alone or in combination. Results represent the mean ± SD of three independent experiments carried out in triplicate. (*) p<0.001 vs CTL.

Image obtained from Hernandez-Flores G et al; BMC Cancer, 2011 Nov 11; 11 : 483

Hernandez-Flores G et al., BMC Cancer, 11, 483, 2011 Reproduced under the Creative Commons license http://creativecommons.org/licenses/by/2.0

Schematic Diagram - Caspase-8 (active) FITC Staining Kit (AB65614)
  • Schematic Diagram

Supplier Data

Schematic Diagram - Caspase-8 (active) FITC Staining Kit (AB65614)

Representative image of Caspase-8 (active) FITC Staining Kit ab65614

Components shown from left to right :

- FITC-IETD-FMK

- Z-VAD-FMK

- Wash Buffer IV (2 bottles)

Note : The vial labels shown in this image use generic names for illustrative purposes only and may not exactly match the specific component names included in the kit.

Note : Colors of solutions in image may not precisely match the shade of colors in the actual kit.

Key facts

Sample types

Suspension cells, Adherent cells

Assay type

Enzyme activity

Assay time

2h

Assay Platform

Microplate reader, Fluor. microscope, Flow cyt.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "Enzyme activity assay": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

Caspase 8 (active) FITC Staining Kit (ab65614) provides a convenient means for sensitive detection of activated caspase 8 in living cells. The assay utilizes the caspase 8 inhibitor, IETD-FMK, conjugated to FITC (FITC-IETD-FMK) as a marker. FITC-IETD-FMK is cell permeable, non-toxic, and irreversibly binds to activated caspase 8 in apoptotic cells. The FITC label allows detection of activated caspase-8 in apoptotic cells directly by fluorescence microscopy, flow cytometry, or fluorescence plate reader. Visit our for tips and troubleshooting.

The Safety Datasheet for this product has been updated for certain countries. Please check the current version in the Support and downloads section.

What's included?

{ "values": { "100Test": { "sellingSize": "100 Test", "publicAssetCode":"ab65614-100Test", "assetComponentDetails": [ { "size":"2 x 100 mL", "name":"Wash Buffer IV", "number":"AB65614-CMP03", "productcode":"" }, { "size":"1 x 100 µL", "name":"FITC-IETD-FMK", "number":"AB65614-CMP01", "productcode":"" }, { "size":"1 x 10 µL", "name":"Z-VAD-FMK", "number":"AB65614-CMP02", "productcode":"" } ] } } }

Properties and storage information

Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
-20°C

Product protocols

Target data

Thiol protease that plays a key role in programmed cell death by acting as a molecular switch for apoptosis, necroptosis and pyroptosis, and is required to prevent tissue damage during embryonic development and adulthood (PubMed : 23516580, PubMed : 35338844, PubMed : 35446120, PubMed : 8681376, PubMed : 8681377, PubMed : 8962078, PubMed : 9006941, PubMed : 9184224). Initiator protease that induces extrinsic apoptosis by mediating cleavage and activation of effector caspases responsible for FAS/CD95-mediated and TNFRSF1A-induced cell death (PubMed : 23516580, PubMed : 35338844, PubMed : 35446120, PubMed : 8681376, PubMed : 8681377, PubMed : 8962078, PubMed : 9006941, PubMed : 9184224). Cleaves and activates effector caspases CASP3, CASP4, CASP6, CASP7, CASP9 and CASP10 (PubMed : 16916640, PubMed : 8962078, PubMed : 9006941). Binding to the adapter molecule FADD recruits it to either receptor FAS/TNFRSF6 or TNFRSF1A (PubMed : 8681376, PubMed : 8681377). The resulting aggregate called the death-inducing signaling complex (DISC) performs CASP8 proteolytic activation (PubMed : 9184224). The active dimeric enzyme is then liberated from the DISC and free to activate downstream apoptotic proteases (PubMed : 9184224). Proteolytic fragments of the N-terminal propeptide (termed CAP3, CAP5 and CAP6) are likely retained in the DISC (PubMed : 9184224). In addition to extrinsic apoptosis, also acts as a negative regulator of necroptosis : acts by cleaving RIPK1 at 'Asp-324', which is crucial to inhibit RIPK1 kinase activity, limiting TNF-induced apoptosis, necroptosis and inflammatory response (PubMed : 31827280, PubMed : 31827281). Also able to initiate pyroptosis by mediating cleavage and activation of gasdermin-C and -D (GSDMC and GSDMD, respectively) : gasdermin cleavage promotes release of the N-terminal moiety that binds to membranes and forms pores, triggering pyroptosis (PubMed : 32929201, PubMed : 34012073). Initiates pyroptosis following inactivation of MAP3K7/TAK1 (By similarity). Also acts as a regulator of innate immunity by mediating cleavage and inactivation of N4BP1 downstream of TLR3 or TLR4, thereby promoting cytokine production (By similarity). May participate in the Granzyme B (GZMB) cell death pathways (PubMed : 8755496). Cleaves PARP1 and PARP2 (PubMed : 8681376). Independent of its protease activity, promotes cell migration following phosphorylation at Tyr-380 (PubMed : 18216014, PubMed : 27109099).. Isoform 5. Lacks the catalytic site and may interfere with the pro-apoptotic activity of the complex.. Isoform 6. Lacks the catalytic site and may interfere with the pro-apoptotic activity of the complex.. Isoform 7. Lacks the catalytic site and may interfere with the pro-apoptotic activity of the complex (Probable). Acts as an inhibitor of the caspase cascade (PubMed : 12010809).. Isoform 8. Lacks the catalytic site and may interfere with the pro-apoptotic activity of the complex.
See full target information CASP8

Publications (8)

Recent publications for all applications. Explore the full list and refine your search

Oncology letters 28:457 PubMed39114572

2024

Metformin in combination with chemotherapy increases apoptosis in gastric cancer cells and counteracts senescence induced by chemotherapy.

Applications

Unspecified application

Species

Unspecified reactive species

Katia Carolina Vázquez-Ibarra,Josefina Yoaly Sánchez López,Tomás Daniel Pineda Razo,José Roberto Cruz Lozano,Brenda Guadalupe Ortiz-Tamayo,Luis Arturo Palafox-Mariscal,Rosa María González Arreola,Juan Ramón González-García,Pablo Cesar Ortiz-Lazareno

Biology 11: PubMed35741451

2022

Identification of a Unique Cytotoxic Thieno[2,3-c]Pyrazole Derivative with Potent and Selective Anticancer Effects In Vitro.

Applications

Unspecified application

Species

Unspecified reactive species

Jessica D Hess,Luca H Macias,Denisse A Gutierrez,Karla Moran-Santibanez,Lisett Contreras,Stephanie Medina,Paulina J Villanueva,Robert A Kirken,Armando Varela-Ramirez,Manuel L Penichet,Renato J Aguilera

eLife 11: PubMed35635436

2022

DNA-damage induced cell death in mutant epidermal basal cells.

Applications

Unspecified application

Species

Unspecified reactive species

Jason K H Lai,Pearlyn J Y Toh,Hamizah A Cognart,Geetika Chouhan,Timothy E Saunders

Scientific reports 11:6250 PubMed33737688

2021

Evaluation of moxifloxacin-induced cytotoxicity on human corneal endothelial cells.

Applications

Unspecified application

Species

Unspecified reactive species

Joo-Hee Park,Martha Kim,Roy S Chuck,Choul Yong Park

Journal of leukocyte biology 110:693-710 PubMed33404106

2021

Selective killing of human M1 macrophages by Smac mimetics alone and M2 macrophages by Smac mimetics and caspase inhibition.

Applications

Unspecified application

Species

Unspecified reactive species

Hamza Ali,Ramon Caballero,Simon X M Dong,Niranjala Gajnayaka,Agatha Vranjkovic,Duale Ahmed,Salma Iqbal,Angela M Crawley,Jonathan B Angel,Edana Cassol,Ashok Kumar

Cancers 12: PubMed33092171

2020

Specific Effects of Trabectedin and Lurbinectedin on Human Macrophage Function and Fate-Novel Insights.

Applications

Unspecified application

Species

Unspecified reactive species

Adrián Povo-Retana,Marina Mojena,Adrian B Stremtan,Victoria B Fernández-García,Ana Gómez-Sáez,Cristina Nuevo-Tapioles,José M Molina-Guijarro,José Avendaño-Ortiz,José M Cuezva,Eduardo López-Collazo,Juan F Martínez-Leal,Lisardo Boscá

Neurotoxicity research 37:743-752 PubMed31997155

2020

Some Ototoxic Drugs Destroy Cochlear Support Cells Before Damaging Sensory Hair Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Dalian Ding,Jianhui Zhang,Haiyan Jiang,Weijun Xuan,Weidong Qi,Richard Salvi

BMC cancer 11:483 PubMed22074157

2011

Pentoxifylline sensitizes human cervical tumor cells to cisplatin-induced apoptosis by suppressing NF-kappa B and decreased cell senescence.

Applications

Unspecified application

Species

Unspecified reactive species

Georgina Hernandez-Flores,Pablo C Ortiz-Lazareno,Jose Manuel Lerma-Diaz,Jorge R Dominguez-Rodriguez,Luis F Jave-Suarez,Adriana del C Aguilar-Lemarroy,Ruth de Celis-Carrillo,Susana del Toro-Arreola,Yessica C Castellanos-Esparza,Alejandro Bravo-Cuellar
View all publications
websiteProtocolBooklet
en

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com